# Discussion

This study argues that the central challenge in SA-AKI mortality modeling is not how to win a retrospective AUROC leaderboard; it is how to construct a clinically legible decision policy when the predictive ceiling is bounded. The canonical benchmark results and the probe evidence point in the same direction. LightGBM-class models are competitive, but their gains over other tabular baselines are modest. The stronger scientific contribution comes from making uncertainty explicit.

Conformal selective triage addresses that problem directly. Instead of forcing every patient into a binary high-risk versus low-risk decision, it partitions the cohort into `Alert`, `Clear`, and `Defer`. That defer region is not a nuisance artifact; it is the mechanism that protects coverage. In this dataset, the defer option is exactly what allows the model to preserve reliable alert PPV and clear NPV under both clean evaluation and shift stress.

The disagreement-based comparator remains useful because it demonstrates that uncertainty-aware action restriction helps even before formal conformalization. However, the disagreement policy depends on an empirically tuned agreement threshold and is harder to justify theoretically. The conformal formulation is stronger for a journal paper because it is more principled, more general, and more transparent about what is and is not guaranteed.

From a translational standpoint, the manuscript supports a narrow but realistic deployment framing: retrospective workflow design, threshold governance, and safe automation boundaries for ICU triage. It does not support bedside deployment or broad generalization claims, and the manuscript should remain explicit about that boundary.
